193 related articles for article (PubMed ID: 37169874)
1. Clonal evolution during metastatic spread in high-risk neuroblastoma.
Gundem G; Levine MF; Roberts SS; Cheung IY; Medina-Martínez JS; Feng Y; Arango-Ossa JE; Chadoutaud L; Rita M; Asimomitis G; Zhou J; You D; Bouvier N; Spitzer B; Solit DB; Dela Cruz F; LaQuaglia MP; Kushner BH; Modak S; Shukla N; Iacobuzio-Donahue CA; Kung AL; Cheung NV; Papaemmanuil E
Nat Genet; 2023 Jun; 55(6):1022-1033. PubMed ID: 37169874
[TBL] [Abstract][Full Text] [Related]
2. Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone.
Abbasi MR; Rifatbegovic F; Brunner C; Mann G; Ziegler A; Pötschger U; Crazzolara R; Ussowicz M; Benesch M; Ebetsberger-Dachs G; Chan GCF; Jones N; Ladenstein R; Ambros IM; Ambros PF
Clin Cancer Res; 2017 Aug; 23(15):4224-4232. PubMed ID: 28228384
[No Abstract] [Full Text] [Related]
3. Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.
Melchardt T; Magnes T; Hufnagl C; Thorner AR; Ducar M; Neureiter D; Tränkenschuh W; Klieser E; Gaggl A; Rösch S; Rasp G; Hartmann TN; Pleyer L; Rinnerthaler G; Weiss L; Greil R; Egle A
Eur J Cancer; 2018 Apr; 93():69-78. PubMed ID: 29477794
[TBL] [Abstract][Full Text] [Related]
4. Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma.
Chicard M; Colmet-Daage L; Clement N; Danzon A; Bohec M; Bernard V; Baulande S; Bellini A; Deveau P; Pierron G; Lapouble E; Janoueix-Lerosey I; Peuchmaur M; Corradini N; Defachelles AS; Valteau-Couanet D; Michon J; Combaret V; Delattre O; Schleiermacher G
Clin Cancer Res; 2018 Feb; 24(4):939-949. PubMed ID: 29191970
[No Abstract] [Full Text] [Related]
5. Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
Padovan-Merhar OM; Raman P; Ostrovnaya I; Kalletla K; Rubnitz KR; Sanford EM; Ali SM; Miller VA; Mossé YP; Granger MP; Weiss B; Maris JM; Modak S
PLoS Genet; 2016 Dec; 12(12):e1006501. PubMed ID: 27997549
[TBL] [Abstract][Full Text] [Related]
6. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of MYCN amplification in neuroblastoma at diagnosis, treatment, relapse, and metastasis.
Marrano P; Irwin MS; Thorner PS
Genes Chromosomes Cancer; 2017 Jan; 56(1):28-41. PubMed ID: 27465929
[TBL] [Abstract][Full Text] [Related]
8. Clonal evolution and expansion associated with therapy resistance and relapse of colorectal cancer.
S A; Chakraborty A; Patnaik S
Mutat Res Rev Mutat Res; 2022; 790():108445. PubMed ID: 36371022
[TBL] [Abstract][Full Text] [Related]
9. Cancer evolution, mutations, and clonal selection in relapse neuroblastoma.
Schulte M; Köster J; Rahmann S; Schramm A
Cell Tissue Res; 2018 May; 372(2):263-268. PubMed ID: 29478075
[TBL] [Abstract][Full Text] [Related]
10. Mutational dynamics between primary and relapse neuroblastomas.
Schramm A; Köster J; Assenov Y; Althoff K; Peifer M; Mahlow E; Odersky A; Beisser D; Ernst C; Henssen AG; Stephan H; Schröder C; Heukamp L; Engesser A; Kahlert Y; Theissen J; Hero B; Roels F; Altmüller J; Nürnberg P; Astrahantseff K; Gloeckner C; De Preter K; Plass C; Lee S; Lode HN; Henrich KO; Gartlgruber M; Speleman F; Schmezer P; Westermann F; Rahmann S; Fischer M; Eggert A; Schulte JH
Nat Genet; 2015 Aug; 47(8):872-7. PubMed ID: 26121086
[TBL] [Abstract][Full Text] [Related]
11. Reorganization of metastamiRs in the evolution of metastatic aggressive neuroblastoma cells.
Khan FH; Pandian V; Ramraj S; Aravindan S; Herman TS; Aravindan N
BMC Genomics; 2015 Jul; 16(1):501. PubMed ID: 26148557
[TBL] [Abstract][Full Text] [Related]
12. Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma.
Lee E; Lee JW; Lee B; Park K; Shim J; Yoo KH; Koo HH; Sung KW; Park WY
BMC Med Genomics; 2020 Nov; 13(1):171. PubMed ID: 33172452
[TBL] [Abstract][Full Text] [Related]
13. Emergence of new ALK mutations at relapse of neuroblastoma.
Schleiermacher G; Javanmardi N; Bernard V; Leroy Q; Cappo J; Rio Frio T; Pierron G; Lapouble E; Combaret V; Speleman F; de Wilde B; Djos A; Ora I; Hedborg F; Träger C; Holmqvist BM; Abrahamsson J; Peuchmaur M; Michon J; Janoueix-Lerosey I; Kogner P; Delattre O; Martinsson T
J Clin Oncol; 2014 Sep; 32(25):2727-34. PubMed ID: 25071110
[TBL] [Abstract][Full Text] [Related]
14. Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database.
Morgenstern DA; London WB; Stephens D; Volchenboum SL; Hero B; Di Cataldo A; Nakagawara A; Shimada H; Ambros PF; Matthay KK; Cohn SL; Pearson AD; Irwin MS
J Clin Oncol; 2014 Apr; 32(12):1228-35. PubMed ID: 24663047
[TBL] [Abstract][Full Text] [Related]
15. Recurrent pre-existing and acquired DNA copy number alterations, including focal TERT gains, in neuroblastoma central nervous system metastases.
Cobrinik D; Ostrovnaya I; Hassimi M; Tickoo SK; Cheung IY; Cheung NK
Genes Chromosomes Cancer; 2013 Dec; 52(12):1150-66. PubMed ID: 24123354
[TBL] [Abstract][Full Text] [Related]
16. The clonal evolution of metastatic colorectal cancer.
Dang HX; Krasnick BA; White BS; Grossman JG; Strand MS; Zhang J; Cabanski CR; Miller CA; Fulton RS; Goedegebuure SP; Fronick CC; Griffith M; Larson DE; Goetz BD; Walker JR; Hawkins WG; Strasberg SM; Linehan DC; Lim KH; Lockhart AC; Mardis ER; Wilson RK; Ley TJ; Maher CA; Fields RC
Sci Adv; 2020 Jun; 6(24):eaay9691. PubMed ID: 32577507
[TBL] [Abstract][Full Text] [Related]
17. Human neuroblastoma demonstrating clonal evolution in vivo.
Gotoh T; Sugihara H; Matsumura T; Katsura K; Takamatsu T; Sawada T
Genes Chromosomes Cancer; 1998 May; 22(1):42-9. PubMed ID: 9591633
[TBL] [Abstract][Full Text] [Related]
18. Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis.
Bellini A; Bernard V; Leroy Q; Rio Frio T; Pierron G; Combaret V; Lapouble E; Clement N; Rubie H; Thebaud E; Chastagner P; Defachelles AS; Bergeron C; Buchbinder N; Taque S; Auvrignon A; Valteau-Couanet D; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
Clin Cancer Res; 2015 Nov; 21(21):4913-21. PubMed ID: 26059187
[TBL] [Abstract][Full Text] [Related]
19. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
20. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
Spitz R; Hero B; Simon T; Berthold F
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
